Towards defining the safer use of opioids in rheumatology

Nat Rev Rheumatol. 2020 Feb;16(2):71-72. doi: 10.1038/s41584-019-0360-1.

Authors

Seoyoung C Kim¹, Daniel H Solomon²

Affiliations

¹ Division of Pharmacoepidemiology and Pharmacoeconomics and Division of Rheumatology, Inflammation and Immunity, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA. sykim@bwh.harvard.edu.
² Division of Pharmacoepidemiology and Pharmacoeconomics and Division of Rheumatology, Inflammation and Immunity, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.

PMID: 31889161
DOI: 10.1038/s41584-019-0360-1

No abstract available

Publication types

Review

MeSH terms

Analgesics, Opioid / adverse effects*
Analgesics, Opioid / therapeutic use
Arthritis, Rheumatoid / drug therapy*
Databases, Factual
Drug-Related Side Effects and Adverse Reactions / mortality
Drug-Related Side Effects and Adverse Reactions / prevention & control*
Humans
Medication Systems, Hospital
Meta-Analysis as Topic
Practice Guidelines as Topic

Substances

Analgesics, Opioid

Grants and funding

R01 AR069557/AR/NIAMS NIH HHS/United States